Hisamitsu Pharmaceutical Co Financials

Hisamitsu Pharmaceutical Stock Summary

Hisamitsu Pharmaceutical competes with Shionogi, Cardiol Therapeutics, Takeda Pharmaceutical, Bausch Health, and Prestige Brand. Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.

Hisamitsu Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Hisamitsu Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Hisamitsu Pharmaceutical reports annually and quarterly.

Hisamitsu Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.Hisamitsu Pharmaceutical Co is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.42  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly  2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Hisamitsu Pharmaceutical Market Pulse

Along with financial statement analysis, the daily predictive indicators of Hisamitsu Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hisamitsu Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hisamitsu Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Hisamitsu Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hisamitsu Pharmaceutical's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in Hisamitsu Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hisamitsu Pharmaceutical's history and understand the potential risks before investing.